Connecticut Mental Health Center

New Haven, Connecticut 06519

12 studies enrolling now · 72 studies all time

What they study most

ADHD, Alcohol Use, Alcohol Use Disorder, Alcohol Use Disorder (AUD), Alcohol-Related Disorders, Bipolar Disorder, Bipolar-I Disorder With Mania or Mania With Mixed Features, Borderline Personality Disorder, CBD, Cannabis, Cannabis Use Disorder, Chronic Low Back Pain (CLBP)

Studies at this site

• A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder — Recruiting now
• Combined THC and CBD for OUD and Chronic Pain — Recruiting now
• Mindfulness-based Neurofeedback to Augment Psychotherapy for Adults With Borderline Personality Disorder — Recruiting now
• Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse — Recruiting now
• The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD) — Recruiting now
• A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects — Recruiting now
• MDMA in Borderline Personality Disorder — Recruiting now
• Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study — Recruiting now
• Toward a Computationally-Informed, Personalized Treatment for Hallucinations — Recruiting now
• Psilocybin-Assisted Physical Therapy in Chronic Low Back Pain — Starting soon
• The Effects of Psilocybin on Social Connectedness — Starting soon
• Effects of Menthol in E-cigarettes on Smoking Behaviors — Completed
• Survey to Test the Nicotine Concentration and Nicotine Flux Labels for E-cigarettes — Starting soon
• CBD-Microglia PET Study — Completed
• CB1R in Synthetic Psychoactive Cannabinoids — Running, not enrolling
• A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study — Stopped early
• Sex Differences in E-cig Perception: Study 1 — Completed
• Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2) — Completed
• Oral Dronabinol-HIV — Running, not enrolling
• Efficacy of Social Cognition Training in Schizophrenia — Completed
• BXCL501 for Agitation in Schizophrenia — Completed
• Imaging the Neurochemistry of Drug Addiction With PET — Completed
• Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study. — Completed
• M1 Schizophrenia PET Study — Completed
• Translational Neuroscience Optimization of GlyT1 Inhibitor — Completed
• Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD — Completed
• Investigation of Cocaine Addiction Using mGluR5 PET and fMRI — Completed
• Fatty Acid Amide Hydrolase (FAAH) Inhibitor Treatment of Cannabis Use Disorder (CUD) — Completed
• Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors — Completed
• Vitamin D and Cocaine Administration — Stopped early
• Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 1H-MRS — Completed
• Ketamine in Borderline Personality Disorder — Stopped early
• Measuring the Impact of Real Time fMRI Neurofeedback in Borderline Personality Disorder — Completed
• FAAH Availability in Psychiatric Disorders: A PET Study — Stopped early
• Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans — Completed
• Impulsivity and Stimulant Administration — Completed
• Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET — Stopped early
• GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration — Completed
• Cannabidiol Treatment in Patients With Early Psychosis — Completed
• Study of Lunesta Versus Placebo for Sleep Problems Related to Smoking Cessation and Zyban — Stopped early
• Enhancement of Therapeutic Learning in OCD Using tDCS — Completed
• Naltrexone for Antipsychotic-Induced Weight Gain — Completed
• Computer Presented and Physical Exercises to Maintain Cognitive Function and Emotional Health in Older Adults — Completed
• Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder — Completed
• Ketamine Infusion for Social Anxiety Disorder — Completed
• PET Imaging in Cocaine Self Administration — Completed
• Culturally Responsive Person-Centered Care for Psychosis — Completed
• Clinical Trial of Abstinence-Linked Money Management — Completed
• Cognitive Training and Enhanced Supported Employment in Schizophrenia — Completed
• Establishing and Eliminating Cue-drug Associations in Human Cocaine Addiction — Stopped early